-
December 09, 2025
COVID-19 vaccines are generally safe, with most Adverse Events Following Immunisation (AEFIs) being minor and resolving on their own
-
September 19, 2023
'Behind every successful woman, there is an understanding man'
-
January 26, 2023
iNCOVACC can produce three immune responses, says Bharat Biotech
-
January 26, 2023
'iNCOVACC' is priced at Rs 800 for private markets
-
January 11, 2023
'The Department will continue to promote and encourage COVID-19 vaccination'
-
December 27, 2022
iNCOVACC is now available on CoWIN portal
-
December 23, 2022
iNCOVACC approved by govt, to be available in private hospitals
-
November 17, 2022
Bharat Biotech condemned the "targeted narrative" against the vaccine
-
August 30, 2022
Only 20 per cent of eligible population have taken the booster dose
-
August 16, 2022
Only 17% of eligible people received precaution dose till Aug 15
-
August 04, 2022
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020
-
July 28, 2022
Departmental probe recommended against Sagar district immunisation officer
-
June 06, 2022
The return to near-normal applied everywhere in Beijing
-
May 03, 2022
Covovax has been included on CoWIN portal for inoculation of children aged 12-17 yrs
-
May 02, 2022
A dose of Covovax will cost Rs 900 plus GST
3tvn257bp2jp4tnjvk2vou6ofh
